KIMBERLY MACNAUL: Open Payments
NPI 1902487051 · CONROE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,302 in 93 payments from 25 companies in 2025. Trend: 2023 $4,035 · 2024 $3,154 · 2025 $2,302
Food & beverage: $2,302
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $305 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $215 |
| ABBVIE INC. | 16 | $204 |
| Otsuka America Pharmaceutical, Inc. | 5 | $178 |
| Kowa Pharmaceuticals America, Inc. | 4 | $163 |
| AstraZeneca Pharmaceuticals LP | 7 | $161 |
| Lilly USA, LLC | 10 | $158 |
| Inspire Medical Systems, Inc. | 1 | $139 |
| Medtronic, Inc. | 4 | $135 |
| Axsome Therapeutics, Inc. | 1 | $112 |
Products named: REXULTI, Kerendia, Wegovy, ZORYVE, INSPIRE, MOUNJARO, QULIPTA, Ozempic.
Industry payments across TX — which companies pay providers there.
